Coronavirus vaccine researcher: Next winter will be normal conditions

It is likely that two German and American companies will jointly launch the first coronavirus vaccine. According to the head of the German company BioNTech, conditions will be normal next winter.

Ugur Sahin, the head of the German company BioNTech, stated in an interview with the BBC World Service that if the joint coronavirus vaccine between BioNTech and Pfizer is released on the market soon, there is high hope that conditions will return to normal by the winter of 2021 (1400).

According to him, with the recent developments in the spread of the new coronavirus (SARS-CoV-2), we will have a difficult winter this year.

He emphasizes that even if his company's vaccine is released to the market this year, it will not have an impact on the number of infected people for the next few months.

BioNTech and Pfizer are preparing to deliver 300 million doses of the vaccine by April next year.

Summer is a good opportunity to reduce the incidence of 

Professor Shahin believes that we will see successes in combating SARS-CoV-2 during the summer, especially since the number of infected people decreases during the hot season.

Despite some German researchers' doubts about the success of the BioNTech and Pfizer vaccines, the European Commission has reached a deal with them on a large contract. The Commission is set to order 300 million doses in an initial phase.

According to Ursula von der Leyen, President of the European Commission, this is currently the most promising vaccine developed to prevent coronavirus infection.

Source: DW